Mosaic Biosciences

Mosaic Biosciences, led by CEO and COO Marty Stanton, is a protein and antibody discovery company that assists its partners in identifying next-generation therapies for disease prevention and treatment. The Mosaic team offers comprehensive end-to-end discovery services, including project evaluation and strategy development; program management; antibody discovery and optimization; protein production, purification, and characterization; protein engineering; biochemical and cell-based assay development; formulation, stability, and developability studies; bioanalytical (PK and PD) assay development; and clinical candidate validation pharmacology. Partners include biopharmaceutical companies, startups, as well as university seed funds and venture capital funds.